Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) Receives GMP Certification From Israel

July 28, 2021

Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI), the developer for autologous adult stem cell therapeutics, is known for debilitating neurodegenerative diseases. Yesterday, the leading developer announced that the Israel Ministry of Health granted it Good Manufacturing Practice approval for its second production site. GMP is granted to the company for state-of-the-art cleanrooms in Tel Aviv, Israel. The company has leased the cleanrooms at Sourasky Hospital, or Tel Aviv Sourasky Medical Center. …

Read More >>